Clinical trial
A Phase II Study of sEphB4-HSA in Kaposi Sarcoma
NCT03993106 is registered in ClinicalTrials.gov with Vasgene Therapeutics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of sEphB4-HSA in Kaposi Sarcoma
- Lead sponsor
- Vasgene Therapeutics, Inc
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 17, 2020
- Completion date
- June 30, 2025
- Enrollment
- 65 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
kaposi sarcoma